Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease

综合基因组、转录组和蛋白质组分析研究阿尔茨海默病的性别特异性差异

基本信息

  • 批准号:
    10370810
  • 负责人:
  • 金额:
    $ 76.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-01 至 2026-12-31
  • 项目状态:
    未结题

项目摘要

Alzheimer's disease (AD) affects 35 million people worldwide. However, there is no effective treatments to slow or halt the underlying neurodegeneration of AD. Strikingly, women are affected by AD about twice as much as men. Why women are disproportionately affected by AD is not well understood. Here, we hypothesize that there is an interaction between biological sex and brain gene expression that predisposes women to have a higher risk for AD. This hypothesis builds on our work investigating the genetic control of gene expression in the human brain. In those studies, we have identified genetic sites that are associated with variation in gene expression at the transcript and protein level in the human brain. Identifying genetic sites associated with natural variation in brain gene expression are incredibly useful to resolve genetic signals identified by genome-wide association study (GWAS) to specific causal transcripts and proteins. We have successfully used brain gene transcript and protein expression results with GWAS results to identify novel proteins for AD (Wingo et al, Nat Genet, 2021) and depression (Wingo et al, Nat Neurosci, 2021). These analyses implicate the causes of inherited genetic risk, which are presumably among the most important early contributors to disease, which make them highly relevant to resolving sex-specific disease risk. To test our hypothesis, we will first perform a sex-specific brain expression analysis for transcripts and proteins (Aim 1). To do this, we will leverage existing brain transcripts and protein expression data generated by national resources, and we propose a novel approach to cost-effectively increase the depth of proteomes to improve power. We expect to generate sex-specific quantitative trait loci (QTL) for brain transcripts (N=1655, 61% women) and proteins (N=1584, 66% women), and each gene will then be tested for evidence of interaction with sex. These results are likely to be of general interest to the neuroscience and genetics communities, and the data and results will be made widely available to the science community. In Aim 2, we will perform a sex-specific GWAS of AD, and we will identify genetic variants that interact with sex. To do this, we will perform sex-stratified GWAS using 1) case-control status for AD in participants from US studies (N=27,580), 2) AD-proxy case-control in participants from the UK Biobank (N=431,000), and iii) a meta- analysis of 1 and 2. In Aim 3, we will identify brain transcripts and proteins contributing to AD pathogenesis that are specific to men or women, respectively. To do this, we will integrate the sex-specific brain QTLs with the sex-specific GWAS results to resolve GWAS signals to proteins for women and men, separately. For AD genetic signals with evidence for sex interaction, we will test whether sex-specific gene expression accounts for the differences in AD risk between the sexes using causal inference approaches (e.g., Mendelian randomization). Findings from this project are highly likely to provide novel mechanistic insights into sex differences in AD and promising new targets for further sex-specific mechanistic and therapeutic studies of AD.
阿尔茨海默病(AD)影响着全世界3500万人。然而,目前还没有有效的治疗方法

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Aliza Pham Wingo其他文献

Aliza Pham Wingo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Aliza Pham Wingo', 18)}}的其他基金

A brain multi-omic approach to identify key molecular drivers of neuropsychiatric symptoms in Alzheimer's dementia
大脑多组学方法识别阿尔茨海默氏痴呆症神经精神症状的关键分子驱动因素
  • 批准号:
    10366260
  • 财政年份:
    2022
  • 资助金额:
    $ 76.39万
  • 项目类别:
A brain multi-omic approach to identify key molecular drivers of neuropsychiatric
识别神经精神关键分子驱动因素的大脑多组学方法
  • 批准号:
    10649953
  • 财政年份:
    2022
  • 资助金额:
    $ 76.39万
  • 项目类别:
A brain multi-omic approach to identify key molecular drivers of neuropsychiatric symptoms in Alzheimer's dementia
大脑多组学方法识别阿尔茨海默氏痴呆症神经精神症状的关键分子驱动因素
  • 批准号:
    10611855
  • 财政年份:
    2022
  • 资助金额:
    $ 76.39万
  • 项目类别:
Identifying Novel Brain Proteins Contributing to PTSD and Alcohol Use Disorder
识别导致创伤后应激障碍和酒精使用障碍的新型脑蛋白
  • 批准号:
    10253128
  • 财政年份:
    2022
  • 资助金额:
    $ 76.39万
  • 项目类别:
Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease
综合基因组、转录组和蛋白质组分析研究阿尔茨海默病的性别特异性差异
  • 批准号:
    10581657
  • 财政年份:
    2022
  • 资助金额:
    $ 76.39万
  • 项目类别:
Identifying Novel Brain Proteins Contributing to PTSD and Alcohol Use Disorder
识别导致创伤后应激障碍和酒精使用障碍的新型脑蛋白
  • 批准号:
    10513311
  • 财政年份:
    2022
  • 资助金额:
    $ 76.39万
  • 项目类别:
BLR&D Research Career Development Transition Award Application
BLR
  • 批准号:
    10012726
  • 财政年份:
    2020
  • 资助金额:
    $ 76.39万
  • 项目类别:
BLR&D Research Career Development Transition Award Application
BLR
  • 批准号:
    10514573
  • 财政年份:
    2020
  • 资助金额:
    $ 76.39万
  • 项目类别:
BLR&D Research Career Development Transition Award Application
BLR
  • 批准号:
    10293592
  • 财政年份:
    2020
  • 资助金额:
    $ 76.39万
  • 项目类别:
Elucidating molecular mechanisms of psychological well-being
阐明心理健康的分子机制
  • 批准号:
    10265336
  • 财政年份:
    2018
  • 资助金额:
    $ 76.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了